AOBCOHORT6
top of page
cooley.png

Athena on Boards | Cohort 6

March 2021 - July 2021 | POWERED BY COOLEY

DAWN BLESSING

VP, Scientific Strategy & Corporate Development

Zogenix

LISA BROCKMAN

SVP, Accounting & Corporate Controller

Mitchell International

LAURA CARTER

Chief Scientific Officer

Gossamer Bio

ANILA DHOKIA

VP, Internal Audit & ERM

Illumina

AMBREEN FAROOK

Sr. Director, Alliance Management & Program Lead

Halozyme

MONIQUE LEVY

Chief Commercial & Strategy Officer

Woebot Health

SHERI OLSON

Sr. Director Product Management, Applications, & Services

Thermo Fisher Scientific

LISA PECORA

VP, Global Finance

NuVasive

JENNY REGAN

CEO

Key Tech

SARAH RICHARDS

Consultant & Science Journalist

​

EIRY ROBERTS

Chief Medical Officer

Neurocrine Biosciences

CHRISTINE SHAW

VP, Assay Development

Genmark Diagnostics

CARRIE (ARIEL) THOMAS

Sr. Manager, Global Market Development

Thermo Fisher Scientific

CARLA VALLONE

President

Portavoce PR

CLAIRE WESTON

Founder & CEO

Reveal Biosciences

HOLLIS WINKLER

VP, Human Resources

Genmark Diagnostics

DANA ZHANG

VP, Finance & Corporate Secretary

Ambrx Inc.

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

TERRY BAYER

Chief Operations Officer

Upfront Resolution

JAYE CONNOLLY-LABELLE

CEO

RippleNami Inc.

KAREN POSSEMATO

VP, Corporate Marketing & Communications

Seer

Athena on Boards Committee

CO-CHAIR

JAYE CONNOLLY-LABELLE

CEO

RippleNami Inc.

CO-CHAIR

CHARITY WILLIAMS

Partner

Cooley

​

SHIRIN ALIPANAH

Head of IT Program Office

Jack In The Box

​

GRACE CHUI-MILLER

Chief Financial Officer

Correlation Ventures

​

BO MONACO

Audit Partner

BDO

bottom of page